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A case-control study was conducted on 91 cases with histologically-confirmed borderline ovarian tumours and 237 con-
trol subjects in hospital for acute non-gynaecological, hormonal or neoplastic disease. Women reporting three or more
births, compared to nulliparae, had a relative risk (RR) estimate of 0.6, but this finding was not statistically significant
(95% confidence interval (CD: 0.2-1.4). The risk of borderline tumours increased, although not significantly, with later
age at first birth: compared to women reporting first birth at age 24 or before, the RRs were 1.3 and 1.7 in those report-
ing respectively their first birth at age 25-29 and 30 years or more. No significant relationship emerged between
borderline ovarian cancer and age at menarche, menopausal status and lifelong menstrual pattern. Cases tended to
report a later age at menopause than controls, but the trend in risk was not statistically significant. Nine cases (9.9%)
and 68 controls (24.9%) reported oral contraceptive use: compared with never users the multivariate RR for ever users
was 0.3, and the risk dropped with duration of use to 0.2 in users for two years or more (X2, trend = 12.70, p<0.001).
This study provides epidemiological evidence of a pathogenetic continuum between borderline and invasive ovarian
tumours.
Borderline ovarian tumours amount to about 10-15%
of malignant ovarian tumours in the epithelial category.
They show many histological characteristics of malig-
nancy, including increased mitotic activity, nuclear ab-
normalities, multilayering of cells, but do not invade
the ovarian stroma, the frequency of their extra-
ovarian spread is low and their clinical course is charac-
terized by low malignancy and high survival rates.1'2
Descriptive epidemiological studies and clinical
series have shown that borderline ovarian tumours are
relatively more common in younger women than in-
vasive carcinomas, and their incidence, as for malig-
nant epithelial neoplasia, is lower in non-white than in
white women.3 Further, the few available analytical
epidemiological data suggest that borderline neoplasia
may share risk factors (e.g. parity or oral contraceptive
use) with invasive cancer,4-5 but no association was
found between borderline ovarian tumours and a family
history of ovarian cancer (a recognized risk factor
for invasive tumours)5"8 in two case-control studies
conducted in the US.8-9
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To obtain further information on the epidemiology
of borderline ovarian tumours, we considered data
from a case-control study conducted in the greater
Milan area, Northern Italy.
SUBJECTS AND METHODS
Since 1986 we have been conducting a case-control
study of borderline ovarian tumours. Trained inter-
viewers identified and questioned women with border-
line ovarian tumour and control subjects. All
interviews were conducted in hospital.
Cases were women aged less than 65 years with
histologically-confirmed diagnosis of borderline
ovarian tumour (according to the World Health
Organization criteria10) who were admitted to the
Second and Fourth Obstetrics and Gynaecology Clinic
of the University of Milan. A total of 91 women aged
23 to 64 years were interviewed. Potential control sub-
jects were women below the age of 65 admitted for
acute non-gynaecological, non-hormonal and non-neo-
plastic conditions to the Ospedale Maggiore (including
the four major teaching and general hospitals in
Milan) and several specialized university clinics, serv-
ing a catchment area comparable to that of the
hospitals where cases had been identified. They were
recruited within the framework of a case-control
surveillance of female genital neoplasms." Out of a
total of 2625 subjects interviewed, 273 controls were
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selected (age range 24-64 years), matched in a 1:3 ratio
within strata of five-year age groups. Of these, 30%
were admitted for traumatic conditions (mostly frac-
tures and sprains), 28% had non-traumatic ortho-
paedic disorders (mostly low back pain and disk
disorders), 17% acute abdominal diseases generally re-
quiring surgery, and 25% other miscellaneous ill-
nesses, such as disorders of the ear, nose, throat or
teeth. Less than 2% of cases and controls refused to be
interviewed. Information was obtained, using a struc-
tured questionnaire, on personal characteristics and
habits, gynaecological and obstetric data, related
medical history, lifetime oral contraceptive or other
female hormone use. Lifelong menstrual pattern was
defined by asking patients whether their lifelong
menstrual pattern was 'regular' or 'irregular' (frequent
menstrual-like episodes of bleeding less than 21 or
more than 35 days apart). Women were defined as
postmenopausal if their last menstrual period occurred
more than one year before the interview. The present
report is based on data collected up to June 1990.
Data Analysis
Odds ratios, as estimators of relative risks (RR), of
borderline ovarian cancer, together with their 95%
approximate confidence intervals (CI), were first com-
puted from data stratified for age by the Mantel-
Haenszel procedure.12 When a factor could be
classified in more than two ordered levels, the signi-
ficance of the linear trend was assessed by the Mantel
test.13
To account simultaneously for the effects of several
potential confounding factors, we used unconditional
multiple logistic regression, with maximum likelihood
fitting.14 Included in the regression equations were
terms for age, education, parity, oral contraceptive
use, age at menopause and, in turn, the other factors
considered.
RESULTS
The distribution of cases and controls according to age
and other major sociodemographic factors (education
and marital status) is shown in Table 1. Cases and con-
trols were similar with reference to education and
marital status: the RR estimates were 1.3 (95% CI:
0.6-2.7) for 12 years of education or more as com-
pared to less than seven, and 1.1 (95% CI: 0.6-2.0) for
married versus never married women (Table 1).
The distribution of cases and controls according to
menstrual history is presented in Table 2. No relation-
ship emerged between borderline ovarian cancer risk
and age at menarche, menopausal status and lifelong
TABLE 1 Distribution of 91 cases of borderline ovarian cancer and 273 controls (and corresponding relative risks)
according to age, education and marital status. Milan, Italy, 1983-1990
Age (years)
<30
30-39
40^t9
50-59
60-64
Education (years)
^ 6
7-11
?12
A;2, trend
Marital status
Never married
Ever married
31
16
12
19
13
32
28
31
27
64
Cases
(34.1)
(17.6)
(13.2)
(20.9)
(14.3)
(35.2)
(30.8)
(34.1)
(29.7)
(70.3)
Controls
86
55
36
57
39
102
92
79
81
192
(31.5)
(20.1)
(13.2)
(20.9)
(14.3)
(37.4)
(33.7)
(28.9)
(29.7)
(70.3)
Relative
Mantel-Haenszel
—
—
—
—
—
It
1.0
(0.5-2.0)
1.3
(0.6-2.7)
0.70(p = 0.40)
It
1.1
(0.6-2.0)
risk (95% CI)
Multiple logistic
regression**
—
—
—
—
—
It
1.0
(0.5-2.0)
1.2
(0.6-2.4)
0.22(p = 0.64)
It
1.2
(0.6-2.4)
•Adjusted for age.
••Including terms for age, education, parity, oral contraceptive use, age at menopause and the above listed variables.
tReference category.
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TABLE 2 Distribution of 91 cases of borderline ovarian cancer and 273 controls (and corresponding relative risks)
according to selected menstrual characteristics. Milan, Italy, 1983-1990
Age at menarche (years)
<12
13-14
5*15
X2, trend
Menopausal status
Pre/in menopause
Postmenopause
Age at menopause (years)
0 0
50-53
5*54
AT2, trend
Lifelong menstrual cycle pattern
Regular
Irregular
Cases
41
39
11
63
28
7
17
4
73
18
Controls
121
120
32
181
92
39
42
11
229t
43
Relative risk
Mantel-Haenszel*
• It
0.9
(0.6-1.6)
1.1
(0.5-2.4)
0.00 (p = 0.97)
It
0.8
(0.4-1.6)
It
2.1
(0.8-5.9)
2.0
(0.5-9.0)
1.31 (p = 0.25)
It
1.3
(0.7-2.4)
(95% CI)
Multiple logistic
regression"
It
1.0
(0.6-1.8)
1.1
(0.5-2.5)
0.06(p = 0.81)
It
0.5
(0.2-1.7)
It
2.7
(0.9-7.6)
2.3
(0.5-10.2)
2.35 (p = 0.13)
It
1.3
(0.6-2.4)
•Adjusted for age.
••Including terms for age, education, parity, oral contraceptive use, age at menopause (when appropriate) and the
above listed variables.
tReference category.
tThe sum does not add up to the total because of missing values.
menstrual pattern. Postmenopausal cases tended to
report a later age at menopause than controls, but the
trend in risk was not statistically significant (X2, trend
1.31, p = 0.25).
Women reporting three or more births were at lower
risk of borderline ovarian cancer than nulliparae, but
this finding (and the overall trend in risk for parity)
was not significant (Table 3). The risk increased with
later age at first birth and, compared to parous women
reporting first birth at age 24 or before, was 1.8 and
2.5 in those reporting first birth at age 25-29 and 30 or
more respectively. This trend in risk was significant
(X2, trend = 5.11, p = 0.02). There was no associa-
tion between spontaneous abortions and borderline
ovarian cancer, but the risk estimate was lower in
women who reported one or more induced abortions
than in those who had none (RR 0.2, 95% CI:
0.1-0.6).
The distribution of cases and controls according to
oral contraceptive use is shown in Table 4. Nine cases
(9.9%) and 68 controls (24.9%) reported oral con-
traceptive use: compared with never users, the age-
adjusted RR for ever users was 0.3 (95% CI: 0.2-0.7)
and the risk decreased to 0.2 in users for two years or
more (X2, trend =10.10, p<0.001).
Multivariate RR estimates were generally consistent
with age-adjusted ones, with the exception of estimates
for age at first birth which tended to be closer to unity;
the corresponding multivariate trend in risk was conse-
quently not statistically significant.
DISCUSSION
The findings of this study indicate that the risk of
borderline ovarian malignancies was lower in oral con-
traceptive users and decreased with duration of use. A
higher risk emerged in women reporting late age at
first birth, in those with no history of induced abortion,
late age at menopause and in nulliparae (but the latter
two findings were not significant).
A major limitation of this study is the small sample
size and hence its limited statistical power. This is
due to the rarity of the disease and should be
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TABLE 3 Distribution of 91 cases of borderline ovarian cancer and 273 controls (and corresponding relative risks)
according to reproductive variables. Milan, Italy, 1983-1990
Parity
0
1-2
>i
X2i trend
Spontaneous abortions
0
>\
Induced abortion
0
>1
Age at first birth (years)
*S24
25-29
5*30
X2, trend
Cases
36
44
11
80
11
88
3
25
19
11
Controls
101
118
54
234
39
233
40
107
46
19
Relative risk
Mantel-Haenszel*
It
1.0
(0.5-1.9)
0.7
(0.2-1.8)
1.46 (p = 0.23)
It
0.8
(0.4-1.8)
It
0.2
(0.1-0.6)
It
1.8
(0.9-3.6)
2.5
(1.0-6.1)
5.11 (p = 0.02)
(95% CI)
Multiple logistic
regression ••
It
1.1
(0.6-2.1)
0.6
(0.2-1.4)
l.54(p = 0.21)
It
0.9
(0.4-2.0)
It
0.2
(0.1-0.8)
It
1.3
(0.6-2.8)
1.7
(0.6-4.6)
1.23 (p = 0.27)
•Adjusted for age.
••Including terms for age, education, parity (when appropriate), oral contraceptive use, age at menopause and the
above listed variables.
tReference category.
TABLE 4 Distribution of 91 cases of borderline ovarian cancer and 273 controls (and corresponding relative risks)
according to oral contraceptive use. Milan, Italy, 1983-1990
Oral contraceptive use
Never used
Ever used
Duration of use (months)
<24
>24
x2\trend
Cases
82
9
5
4
Controls
205
68
30
38
Relative
Mantel-Haenszel'
It
0.3
(0.2-0.7)
0.3
(0.1-0.9)
0.2
(0.1-0.7)
10.10 (p<0.001)
risk (95% CI)
Multiple logistic
regression**
It
0.3
(0.2-O.6)
0.3
(0.1-0.4)
0.2
(0.1-0.6)
12.70 (p<0.001)
•Adjusted for age.
"Including terms for age, education, parity, age at menopause and oral contraceptive use.
tReference category.
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TABLE 5 Relative risk estimates of borderline and invasive ovarian
cancer emerging from a case-control survey conducted in the greater
Milan area (present study and 20, 30, 32). 1983-1990
Parity
0
1
3=2
Age at first birth (years)
<22
22-24
25-27
>28
Age at menarche (years)
5=13
<13
Age at menopause (years)
<45
45-49
50-53
£54
Oral contraceptive use (years)
Never
<2
>2
Relative risk
Borderline
tumours
It
1.1
0.6
It
1.3*
1.7"
It
1.0
It
2.7
2.3
It
0.3
0.2
Malignant
tumours
It
0.7
0.7
It
2.9
3.0
3.3
It
1.1
It
1.3
1.4
1.6
It
0.9
0.5
t Reference category.
• 25-29.
considered in the interpretation of results. In relation
to potential biases, selection should not markedly in-
fluence the findings since cases and controls were iden-
tified in institutions covering comparable catchment
areas and participation was almost complete. Our con-
trol group consisted of women in hospital for a large
number of acute conditions, and it is conceivable that
specific conditions may be selectively associated with
some of the factors considered. For example trauma is
associated with osteoporosis, which, in turn, is pos-
sibly related with obstetric and reproductive history.l5
However the RR estimates were largely consistent
when analysis was performed considering separately
main categories of controls (trauma, other ortho-
paedics, surgical and other). Furthermore, hospital
controls are likely to provide information more com-
parable to that of cases than population controls. Our
interviewers were not blind to the case-control status,
but they were not aware of the specific endpoints of
this analysis. In general, it is unlikely that information
bias is a major problem in the definition of reproduc-
tive and menstrual characteristics or of general lifestyle
or socioeconomic indicators, particularly in younger
women.16 With regard to confounding, allowing for
potential covariates did not materially modify the
estimated RRs.
Few analytical epidemiological studies have been
published on risk factors for borderline ovarian
cancer. This study provides further data on the issue
and allows comparison with studies on the epidemi-
ology of malignant ovarian tumours. Two case-control
studies conducted in the US on borderline ovarian
malignancies found a negative association with in-
creasing parity4'5 and an increased risk of the disease
associated with number of miscarriages emerged in one
study.4 In the present study the protection given by
parity was restricted to multiparae (and not statistically
significant, possibly because of the small sample size).
Late age at first birth was associated with an increased
risk in this study, but not in a previous one.4
The lower risk of borderline ovarian cancer
observed in this study in women reporting induced
abortions can be tentatively interpreted in terms of
higher fertility in women requiring induced abor-
tions. l7>18 A greater risk of borderline ovarian cancer in
ever-married nulliparous women reporting a history of
infertility was also observed in an American case-
control study.4
The role of parity and early age at first birth19"21 in
ovarian carcinogenesis is incompletely understood, the
relevant issue being whether nulliparity per se or dif-
ficulty in conception facilitates the development of
ovarian cancer. Most studies on malignant disease
report a lower risk in parous than in nulliparous
women, but the protection provided by more than one
pregnancy is generally weak.17 Furthermore, since
multiparous women usually start reproduction early in
their life, the independent effects of age at first birth
and parity is difficult to establish.
In this and a previous study4 oral contraceptive
users had about 70% lower risk of borderline
tumours. The protection provided by combined oral
contraceptives on subsequent ovarian cancer risk is
well established in epithelial invasive ovarian car-
cinogenesis. 22'23 Similar, but not completely consistent,
evidence emerged from functional and seromucinous
ovarian cysts.24"27 These findings underline the protec-
tive effect of oral contraceptives on the whole spec-
trum of ovarian tumours.
Another potential similarity between borderline and
invasive ovarian cancer21-28"31 concerns menstrual
characteristics. In this study, no relationship was
observed between borderline ovarian cancer and age at
menarche, but cases did tend to report a later age at
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menopause, although this was not statistically signifi-
cant. Similar findings emerged in an American case-
control study.5
In conclusion, this study gives more detailed infor-
mation on the epidemiology of borderline ovarian
cancer and provides evidence of similarities between
borderline and invasive ovarian tumour epidemiology
including: a substantial protection by oral contracep-
tives on the two histological subtypes; a possible,
although moderate, protective effect of high parity
and of an early age at first birth; an increased risk in
women with late age at menopause, but no substantial
relationship with age at menarche. In biological terms
these findings can be interpreted within the framework
of the 'incessant ovulation' hypothesis in ovarian car-
cinogenesis, where ovulation or 'ovulatory cycles' are
the relevant exposure which defines the incidence of
the neoplastic lesions, thus suggesting an epidemio-
logical continuum between various grades of malig-
nancy of epithelial ovarian neoplasms.
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